Investing Profile

Tom Burt

InvestorVC
Partner at Sofinnova Partners
Photo of Tom Burt, Partner at Sofinnova Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Business School Network
624 CONNECTIONS
UCL Network
104 CONNECTIONS
University of Leeds Network
33 CONNECTIONS
GSK Network
32 CONNECTIONS
Sofinnova Partners Network
32 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Synthace
Series CNov 2021$35M
$75M
Co-investors: Bill Liao (SOSV), Isabel Fox (Luminous Ventures), Hermann Hauser (Amadeus Capital Partners), Sharaf Yamani, Sami Mikati
Sphere Bio
Series UnknownOct 2021$41M
$41M
Research Engineer GlaxoSmithKlinePresent
Research Engineer GSKPresent
Associate, Healthcare Investment Banking Piper JaffrayPresent
Associate, Novo Growth Equity Novo HoldingsPresent
Investment Director B-FLEXIONPresent
Senior Research Analyst [Healthcare & Life Sciences] Peel HuntPresent
Head of Life Sciences Triton PartnersPresent
Partner Sofinnova PartnersPresent
University of Leeds B.Sc. Biotechnology
University of Birmingham M.Sc. (Eng) Biochemical Engineering
UCL Eng.D. Biochemical Engineering & Bioprocess Leadership
Harvard Business School - VC/PE Module